Department of Pharmacological and Biomolecular Sciences, University of Milan, Via Balzaretti 9, Milan, Italy.
Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, New York University Grossman School of Medicine, 550 1st Ave., New York, NY, USA.
Cardiovasc Res. 2023 Aug 19;119(10):1905-1914. doi: 10.1093/cvr/cvad100.
A fine balance between uptake, storage, and the use of high energy fuels, like lipids, is crucial in the homeostasis of different metabolic tissues. Nowhere is this balance more important and more precarious than in the heart. This highly energy-demanding muscle normally oxidizes almost all the available substrates to generate energy, with fatty acids being the preferred source under physiological conditions. In patients with cardiomyopathies and heart failure, changes in the main energetic substrate are observed; these hearts often prefer to utilize glucose rather than oxidizing fatty acids. An imbalance between uptake and oxidation of fatty acid can result in cellular lipid accumulation and cytotoxicity. In this review, we will focus on the sources and uptake pathways used to direct fatty acids to cardiomyocytes. We will then discuss the intracellular machinery used to either store or oxidize these lipids and explain how disruptions in homeostasis can lead to mitochondrial dysfunction and heart failure. Moreover, we will also discuss the role of cholesterol accumulation in cardiomyocytes. Our discussion will attempt to weave in vitro experiments and in vivo data from mice and humans and use several human diseases to illustrate metabolism gone haywire as a cause of or accomplice to cardiac dysfunction.
在不同代谢组织的动态平衡中,吸收、储存和利用高能燃料(如脂质)之间的平衡至关重要。这种平衡在心脏中尤为重要和脆弱。作为一个高耗能的肌肉,心脏通常会氧化几乎所有可用的底物来产生能量,在生理条件下,脂肪酸是首选的能量来源。在心肌病和心力衰竭患者中,观察到主要能量底物发生变化;这些心脏通常更愿意利用葡萄糖而不是氧化脂肪酸。脂肪酸的摄取和氧化之间的不平衡会导致细胞内脂质积累和细胞毒性。在这篇综述中,我们将重点关注用于将脂肪酸引导至心肌细胞的来源和摄取途径。然后,我们将讨论用于储存或氧化这些脂质的细胞内机制,并解释动态平衡的破坏如何导致线粒体功能障碍和心力衰竭。此外,我们还将讨论胆固醇在心肌细胞中的积累作用。我们的讨论将尝试整合来自小鼠和人类的体外实验和体内数据,并利用几种人类疾病来说明代谢紊乱作为心脏功能障碍的原因或帮凶。
Cardiovasc Res. 2023-8-19
Am J Physiol Heart Circ Physiol. 2019-5-1
Biochim Biophys Acta Mol Basis Dis. 2019-10-31
Circ Res. 2021-5-14
Am J Physiol Endocrinol Metab. 2013-10-1
J Mol Cell Cardiol. 2005-10
Cell Commun Signal. 2025-9-2
Front Pharmacol. 2025-8-4
Am J Physiol Cell Physiol. 2025-8-1
J Mol Cell Cardiol Plus. 2025-6-10
Oxid Med Cell Longev. 2022
J Clin Invest. 2022-3-15
Biomolecules. 2021-7-12